IMAGE: Combining a tiny drug capsule — a nanocarrier — with antibodies under acidic conditions results in the antibodies attaching to the drug carrier in a stable way. This makes it… view more
Credit: Ill./©: Stefan Schuhmacher
Scientists at the Mainz University Medical Center and the Max Planck Institute for Polymer Research (MPI-P) have developed a new method to enable miniature drug-filled nanocarriers to dock on to immune cells, which in turn attack tumors. In the future, this may lead to targeted treatment that can largely eliminate damage to healthy tissue. The scientists have recently published their findings in the renowned scientific journal Nature Nanotechnology. Please watch https://www.youtube.com/watch?v=ZFVnBBWhCro for further information on the way nanocarriers work and function.
In modern medicine, patients receiving medication to treat tumors or for pain therapy are often given drugs that disperse throughout the entire body, even though the section of the organ to be treated may be only small and clearly demarcated. One solution would be to administer drugs that target specific cell types. Such nanocarriers are just what scientists are working to develop. These contain, in a manner of speaking, miniature submarines no larger than a thousandth of the diameter of a
Article originally posted at